相似文献
1
[Pharmacovigilance: theoretical and practical aspects].
Clin Ter. 1997 Mar;148(3):67-73.
2
[Pharmacovigilance: a case of phantom ships and Russian roulette].
Ned Tijdschr Geneeskd. 2002 Jul 6;146(27):1258-61.
3
A model for the future conduct of pharmacovigilance.
Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):17-29. doi: 10.1002/pds.773.
4
European commission consultation on pharmacovigilance.
Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9. doi: 10.1002/pds.1526.
5
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1176-84. doi: 10.1002/pds.1836.
6
[Pharmacovigilance in pharmacy practice].
J Pharm Belg. 2011 Dec(4):97-103.
7
An appraisal of spontaneous adverse event monitoring.
Adverse Drug React Toxicol Rev. 1992 Winter;11(4):213-27.
8
FDA attempting to overcome major roadblocks in monitoring drug safety.
J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872.
9
International monitoring for adverse drug reactions of long latency.
Adverse Drug React Toxicol Rev. 1991 Winter;10(4):209-30.
10
Postmarketing surveillance.
Handb Exp Pharmacol. 2011;205:339-51. doi: 10.1007/978-3-642-20195-0_17.
Zotero 插件